Physician profile
Peter Burke
NPI 1770605198
$37,046.08
in general payments reported to CMS, 2019-2025
43 companies · $737 in 2025
The $737 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,470 · 2020: $1,195 · 2021: $9,106 · 2022: $18K · 2023: $1,958 · 2024: $4,902 · 2025: $737.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,855 · Travel and Lodging: $3,442 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,855.26 |
| Travel and Lodging | $3,441.53 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $300.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $20,643.39 | 2019-2024 | Xarelto |
| Medtronic, INC. | $4,957.46 | 2021-2025 | In.Pact Admiral, Abre, Hawkone |
| Inari Medical, INC. | $4,320.88 | 2020-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Novartis Pharmaceuticals Corporation | $731.24 | 2019-2024 | |
| Amgen INC. | $692.66 | 2019-2024 | Repatha |
| Pfizer INC. | $575.70 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $551.26 | 2019-2024 | Jardiance |
| Astrazeneca Pharmaceuticals Lp | $549.51 | 2019-2024 | Wainua, Brilinta |
| Boston Scientific Corporation | $394.68 | 2019-2025 | Watchman Flx |
| Bayer Healthcare Pharmaceuticals INC. | $381.11 | 2020-2024 | |
| Medtronic Vascular, INC. | $361.97 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $296.07 | 2019-2023 | Camzyos |
| Amarin Pharma, INC. | $254.31 | 2020-2022 | |
| Philips North America LLC | $250.20 | 2023-2025 | IV Other |
| Shockwave Medical, INC | $229.12 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave E8 Peripher |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $204.21 | 2020-2024 | Cardiomems |
| Stryker Corporation | $200.02 | 2025 | Clottriever Bold Catheter, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Sanofi-Aventis U.S. LLC | $191.48 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $171.53 | 2021-2024 | Verquvo |
| Lundbeck LLC | $125.71 | 2019-2021 | |
| Alnylam Pharmaceuticals INC. | $120.98 | 2021-2025 | Amvuttra |
| Baxter Healthcare | $106.17 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Preventice Services, LLC | $87.72 | 2019-2021 | |
| Novo Nordisk INC | $86.13 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $73.90 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $71.75 | 2019-2022 | |
| Kowa Pharmaceuticals America, INC. | $57.81 | 2019-2022 | |
| Daiichi Sankyo INC. | $52.03 | 2020-2021 | |
| Esperion Therapeutics, INC. | $45.89 | 2020-2021 | |
| Cardiovascular Systems INC. | $38.37 | 2021-2022 | |
| Cardiva Medical, INC. | $24.74 | 2021 | |
| Edwards Lifesciences Corporation | $22.14 | 2021 | |
| Chiesi USA, INC. | $21.48 | 2022 | |
| Livanova USA, INC. | $18.60 | 2022 | |
| Tactile Systems Technology INC | $18.45 | 2024 | Entre Plus, Flexitouch Plus |
| Bardy Diagnostics, INC. | $16.82 | 2022 | |
| Biotronik INC. | $16.76 | 2020 | |
| Impulse Dynamics (USA) INC. | $16.18 | 2022 | |
| Astellas Pharma US INC | $15.20 | 2020 | |
| Abiomed | $15.07 | 2025 | |
| Teleflex LLC | $13.98 | 2023 | Trapliner |
| Biosense Webster, INC. | $12.26 | 2021 | |
| Gilead Sciences, INC. | $11.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Burke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.